Search results for "Prospective"

showing 10 items of 3738 documents

Intraprocedural bowel cleansing with the JetPrep cleansing system improves adenoma detection.

2014

AIM: To investigate the impact of JetPrep cleansing on adenoma detection rates. METHODS: In this prospective, randomized, crossover trial, patients were blindly randomized to an intervention arm or a control arm. In accordance with the risk profile for the development of colorectal carcinoma, the study participants were divided into high-risk and low-risk groups. Individuals with just one criterion (age > 70 years, adenoma in medical history, and first-degree relative with colorectal cancer) were regarded as high-risk patients. Bowel preparation was performed in a standardized manner one day before the procedure. Participants in the intervention arm underwent an initial colonoscopy with sta…

AdenomaMalemedicine.medical_specialtyRandomizationendocrine system diseasesColorectal cancerColonoscopyTherapeutic irrigationColonic PolypsGroup BAdenomatous PolypsPredictive Value of TestsRisk FactorsMedicineHumansProspective StudiesDiagnostic ErrorsProspective cohort studyTherapeutic IrrigationEarly Detection of CancerAgedCross-Over Studiesmedicine.diagnostic_testbusiness.industryGastroenterologyGeneral MedicineColonoscopyEquipment DesignMiddle Agedmedicine.diseasePrognosisCrossover studydigestive system diseasesSurgerystomatognathic diseasesPredictive value of testsRandomized Controlled TrialFemalebusinessColorectal NeoplasmsWorld journal of gastroenterology
researchProduct

Standardized long-term follow-up after endoscopic resection of large, nonpedunculated colorectal lesions: a prospective two-center study.

2014

Endoscopic removal of large, nonpedunculated colorectal lesions is challenging. Long-term outcome data based on standardized protocols, including detailed inspection of the resection site, are scarce. The aims of the present study were to evaluate the safety and efficacy of endoscopic resection (ER) of large, nonpedunculated lesions (LNLs;20 mm) and to assess the long-term recurrence rate afterward.A total of 243 consecutive patients (141 men, 102 women) with 252 adenomas (20 mm) was followed up using a standardized protocol after complete ER. After endoscopic treatment, the patients received standardized follow-up examinations after 3-6 months and 12 months. The postpolypectomy scar was re…

AdenomaMalemedicine.medical_specialtyTime FactorsLong term follow upColonic PolypsGastroenterologyRisk AssessmentCohort StudiesPostoperative ComplicationsInternal medicineGermanyBiopsymedicineHumansEndoscopic resectionNeoplasm InvasivenessProspective StudiesProspective cohort studySurvival rateAgedMonitoring PhysiologicNeoplasm StagingAged 80 and overHepatologymedicine.diagnostic_testbusiness.industryBiopsy NeedleGastroenterologyFollow up studiesColonoscopyMiddle AgedImmunohistochemistrySurvival RateNeoplasm stagingFemaleRadiologyNeoplasm Recurrence LocalbusinessColorectal NeoplasmsCohort studyFollow-Up StudiesThe American journal of gastroenterology
researchProduct

Clinical results of transanal endoscopic microsurgery

1988

Using the "transanal endoscopic microsurgery" technique, 140 patients were treated at the Department of Surgery in Cologne and Mainz. Of the patients with adenomas, 68.2% had typical symptoms preoperatively. The postoperative hospital attendance was 8.7 days, with an average resection size of 14.4 cm2. The postoperative complication rate was 5%, and there were no deaths related to the technique. In a prospective controlled trial, 2.2% of the patients with adenomas treated endoscopically in Mainz showed recidivation, requiring reoperation. The follow-up rate was 100%. In 30 cases, microscopic examination revealed carcinoma. Radical reoperation in 8 pT1 tumours showed neither remaining tumour…

AdenomaReoperationMicrosurgerymedicine.medical_specialtyAdenomamedicine.medical_treatmentRectummedicineCarcinomaHumansProspective StudiesLymph nodeClinical Trials as Topicmedicine.diagnostic_testRectal Neoplasmsbusiness.industryIntestinal PolypsPostoperative complicationColonoscopyMicrosurgerymedicine.diseaseEndoscopySurgerymedicine.anatomical_structureColonic NeoplasmsSurgeryNeoplasm Recurrence LocalbusinessAbdominal surgerySurgical Endoscopy
researchProduct

Developmental outcomes in adolescence of children with autism spectrum disorder without intellectual disability: A systematic review of prospective s…

2021

Individuals with Autism Spectrum Disorder (ASD) without intellectual disability (ID) represent approximately two-thirds of the ASD population. Here we focused on prospective research assessing different areas of functioning of children with ASD, without ID, until adolescence. Based on a pre-registered protocol (PROSPERO CRD42020189029), a systematic review of prospective studies (published between 01.01.2010 and 01.01.2020) was conducted. Twenty-eight studies met eligibility criteria. Findings indicated that ASD diagnosis and the Intelligence Quotient were highly stable over time across studies. Executive Functioning, Theory of Mind and Central Coherence processes tended to improve, althoug…

AdolescentAutism Spectrum DisorderCognitive NeurosciencePopulationComorbidityExecutive FunctionBehavioral NeuroscienceSocial skillsIntellectual DisabilityTheory of mindmental disordersIntellectual disabilitymedicineHumansProspective StudiesChildeducationeducation.field_of_studyIntelligence quotientmedicine.diseaseExecutive functionsNeuropsychology and Physiological PsychologyAutism spectrum disorderAutismPsychologyClinical psychologyNeuroscience & Biobehavioral Reviews
researchProduct

Comparison of combined application treatment with one-visit varnish treatments in an orthodontic population

2013

Objective: To evaluate the effect of chlorhexidine-thymol varnish alone, its combination with chlorhexidine-fluo - ride containing dentifrice and fluoride varnish on oral hygiene and caries prevention in orthodontic patients. Study design: Sixty patients, aged 12-18, with orthodontic fixed appliances were randomly assigned into three groups as follows: Group 1 (n=20): 1% chlorhexidine and 1% thymol varnish (Cervitec ® Plus); Group 2 (n=20): Cervitec ® Plus+ 0.2% chlorhexidine and 0.2% sodium fluoride (900 ppm fluoride) (Cervitec ® Gel)); and Group 3 (n=20): 0.1% fluoride varnish (Fluor Protector ® ). Mutans streptococci (MS), lactobacilli (LB) levels, buffering capacity (BC), visible plaque…

AdolescentOffice VisitsPopulationDentistryOrthodonticsOdontologíaDental CariesOral hygieneOrthodontics Correctivechemistry.chemical_compoundGingivitisFluoridesSodium fluorideDentifricemedicineHumansFluorides TopicalSingle-Blind MethodProspective StudieseducationChildGeneral DentistryOrthodonticseducation.field_of_studybusiness.industryChlorhexidineFluoride varnishChlorhexidine:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludThymolDrug CombinationsOtorhinolaryngologychemistryUNESCO::CIENCIAS MÉDICASAnti-Infective Agents LocalSurgeryResearch-Articlemedicine.symptombusinessFluorideToothpastesmedicine.drug
researchProduct

The influence of change on sense of coherence on dental services use among adolescents: a two-year prospective follow-up study.

2021

Abstract Background To investigate the influence of change on sense of coherence (SOC) on dental services use in adolescents over a two-year period. Methods A prospective follow-up study was conducted involving 334 12-year-old adolescents from public schools in the city of Manaus, Amazonas, Brazil. The predictors of use of dental services in the last 12 months were selected according to the Andersen’s behavioural theoretical model. The predisposing factors included sex, self-reported skin colour and SOC. The enabling factors were dental insurance, monthly family income and parents/guardians schooling. Dental pain, perceived oral health status, dental caries and gingival status were used to …

AdolescentSense of CoherenceResearchRK1-715Oral HealthVDP::Medical disciplines: 700::Health sciences: 800Dental CariesAdolescentsDental health servicesstomatognathic diseasesCross-Sectional Studiesstomatognathic systemDentistryHumansProspective StudiesChildDental CareGeneral DentistryBrazilFollow-Up StudiesBMC oral health
researchProduct

Relationship between apoptosis and survival molecules in human cumulus cells as markers of oocyte competence

2017

SummaryTo select from a single patient the best oocytes able to reach the blastocyst stage, we searched for valuable markers for oocytes competence. We evaluated the DNA fragmentation index (DFI) and the level of some survival molecules, such as AKT, pAKT and pERK1/2, in individual cumulus cell–oocyte complexes (COC). The study included normo-responder women. The average age of the patients was 34.3. DFI in cumulus cells was evaluated using the terminal deoxynucleotidyl transferase (TdT) dUTP nick-end labelling (TUNEL) assayin situ. AKT, pAKT and pERK1/2 were measured by immunological assay and densitometric analysis of fluorescent signals using NIS-Elements BR 3.10 image software. Statisti…

Adult0301 basic medicineCell SurvivalApoptosisDNA FragmentationBiologyMolecular markerAndrology03 medical and health sciences0302 clinical medicineOocyte competencemedicineHumansProspective StudiesBlastocystPhosphorylationSettore BIO/06 - Anatomia Comparata E CitologiaExtracellular Signal-Regulated MAP KinasesCells CulturedCumulus Cells030219 obstetrics & reproductive medicineTUNEL assayApoptosiEmbryoCell BiologyOocyteIn vitroCell biology030104 developmental biologymedicine.anatomical_structureHuman cumulus cellTerminal deoxynucleotidyl transferaseApoptosisSurvival moleculeOocytesDNA fragmentationFemaleProto-Oncogene Proteins c-aktBiomarkersDevelopmental Biology
researchProduct

Impact of granulocyte colony-stimulating factor (G-CSF) and epoetin (EPO) on hematologic toxicities and quality of life in patients during adjuvant c…

2020

Hematologic toxicities are one of the greatest challenges in adjuvant chemotherapy for breast cancer. This analysis of the ADEBAR trial aims to evaluate application and effect of granulocyte colony-stimulating factor (G-CSF) and epoetin alfa (EPO) on hematologic parameters and fatigue in patients with breast cancer during chemotherapy.In the ADEBAR trial, 1493 patients with node-positive primary breast cancer were randomized to either 6 × 5-fluorouracil, epirubicin, and cyclophosphamide (FEC120) or 4 × epirubicin and cyclophosphamide followed by 4 × docetaxel (EC-DOC). Co-medication with G-CSF or EPO was applied to treat chemotherapy-induced leukopenia or anemia. Fatigue was assessed at bas…

Adult0301 basic medicineOncologyCancer Researchmedicine.medical_specialtyAdolescentCyclophosphamidemedicine.medical_treatmentBreast NeoplasmsSeverity of Illness IndexHemoglobinsLeukocyte CountYoung Adult03 medical and health sciences0302 clinical medicineBreast cancerInternal medicineAntineoplastic Combined Chemotherapy ProtocolsGranulocyte Colony-Stimulating FactormedicineHumansProspective StudiesFatigueAgedNeoplasm StagingChemotherapyLeukopeniabusiness.industryEpoetin alfaAnemiaLeukopeniaMiddle Agedmedicine.diseaseGranulocyte colony-stimulating factorEpoetin Alfa030104 developmental biologyOncologyDocetaxelChemotherapy Adjuvant030220 oncology & carcinogenesisQuality of LifeFemalemedicine.symptombusinessmedicine.drugEpirubicin
researchProduct

Pooled analysis of prospective European studies assessing the impact of using the 21-gene Recurrence Score assay on clinical decision making in women…

2016

PURPOSE: The 21-gene Recurrence Score assay (Oncotype DX) provides prognostic/predictive information in oestrogen receptor positive (ER+) early breast cancer, but access/reimbursement has been limited in most European countries in the absence of prospective outcome data. Recently, two large prospective studies and a real-life 5-year outcome study have been reported. We performed a pooled analysis of prospective European impact studies to generate robust data on impact of use in different clinical subgroups. METHODS: The analysis included four studies (French, German, Spanish, and British) in ER+ human epidermal growth factor receptor 2-negative breast cancer patients (n = 527). Node-positiv…

Adult0301 basic medicineOncologyCancer Researchmedicine.medical_specialtyReceptor ErbB-2medicine.medical_treatmentClinical Decision-MakingBreast NeoplasmsMama -- Càncer -- TractamentRisk AssessmentSeverity of Illness Index03 medical and health sciencesBreast cancer0302 clinical medicineBreast cancerInternal medicineQuimioteràpiaHumansMedicineProspective StudiesOestrogen receptorPrecision MedicineStage (cooking)Prospective cohort studyReimbursementAgedAged 80 and overGynecologyChemotherapyIndividualised medicinemedicine.diagnostic_testbusiness.industryGene Expression ProfilingMiddle Agedmedicine.diseaseTumor BurdenAdjuvant chemotherapyEurope030104 developmental biologyReceptors EstrogenOncology030220 oncology & carcinogenesisHormonal therapyFemaleNeoplasm Recurrence LocalbusinessOncotype DXClinical decision makingEuropean Journal of Cancer
researchProduct

A Roma founder BIN1 mutation causes a novel phenotype of centronuclear myopathy with rigid spine

2018

ObjectiveTo describe a large series of BIN1 patients, in which a novel founder mutation in the Roma population of southern Spain has been identified.MethodsPatients diagnosed with centronuclear myopathy (CNM) at 5 major reference centers for neuromuscular disease in Spain (n = 53) were screened for BIN1 mutations. Clinical, histologic, radiologic, and genetic features were analyzed.ResultsEighteen patients from 13 families carried the p.Arg234Cys variant; 16 of them were homozygous for it and 2 had compound heterozygous p.Arg234Cys/p.Arg145Cys mutations. Both BIN1 variants have only been identified in Roma, causing 100% of CNM in this ethnic group in our cohort. The haplotype analysis confi…

Adult0301 basic medicinemedicine.medical_specialtyRomaNeuromuscular diseaseAdolescentPopulationMallory BodiesCompound heterozygosityArticleMuscular DystrophiesCohort StudiesYoung Adult03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumansProspective StudiesCentronuclear myopathyChildeducationProspective cohort studyAdaptor Proteins Signal TransducingRetrospective Studieseducation.field_of_studybusiness.industryTumor Suppressor ProteinsHaplotypeNuclear ProteinsRetrospective cohort studyMiddle Agedmedicine.diseaseFounder EffectPhenotype030104 developmental biologyScoliosisSpainMutation[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]Neurology (clinical)business030217 neurology & neurosurgeryMyopathies Structural CongenitalFounder effect
researchProduct